Biotech Values

[dewophile]

mnta
my point is simply that the response to this complaint could also have implications for where the FDA stands visa vie TEVA since both companies claim to have met "samenss" and are perplexed regarding immmunogenicity (with amphastar also having issues with the supply chain - something TEVA may or may not be having issues with)